A Phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed diffuse large B cell lymphoma Grade IIIb Follicular Lymphoma transformed lymphoma and high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements

Brief description of study

A Phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed diffuse large B cell lymphoma, Grade IIIb Follicular Lymphoma, transformed lymphoma, and high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements


Clinical Study Identifier: s21-01259
ClinicalTrials.gov Identifier: NCT04799275
Principal Investigator: Catherine M Diefenbach.
Other Investigators: Kenneth B Hymes, Marc Justin Braunstein, Jaime Andres Suarez Londono, Vathveal Mathews, Michael L. Grossbard, Bonnie Kiner-Strachan, Bruce G Raphael, Maxim Kreditor, John Leslie Vaughn, Michael E Garrison, Elizabeth Ann Roman, Jingmei Hsu, Elizabeth A Raetz, Shella Saint Fleur-Lominy, David Kaminetzky, Kathryn Dowling, Tibor Moskovits, Ellaine R Yap, Thaleshravi Prashad.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.